Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone

Circulation Research

Volumn 103, Issue 3, 2008, Pages 315-324

  Peter, Bernhard Friedrich ^a   Lidington, Darcy ^a,b   Harada, Aki ^c   Bolz, Hanno Jörn ^b,d   Vogel, Lukas ^a   Heximer, Scott ^b   Spiegel, Sarah ^c   Pohl, Ulrich ^a   Bolz, Steffen Sebastian ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Ca2; Cystic fibrosis transmembrane regulator; Myogenic response; Sensitization; Signal transduction; Transfection; Vascular smooth muscle

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE PHOSPHOHYDROLASE 1; SPHINGOSINE KINASE 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PHOSPHATASE; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE-1-PHOSPHATE PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM ABSORPTION; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GRACILIS MUSCLE; HAMSTER; MUTANT; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; TISSUE PERFUSION; VASOCONSTRICTION; ANIMAL; ARTERY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; PHYSIOLOGY; VASCULAR RESISTANCE;

ANIMALS; ARTERIES; CATALYSIS; CRICETINAE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MEMBRANE PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 53549084071     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.173575     Document Type: Article

References (26)

1. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4:397-407.
2. Mattie M, Brooker G, Spiegel S. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem. 1994;269:3181-3188.
3. Van Brocklyn J, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O, Thomas DM, Coopman PJ, Thangada S, Liu CH, Hla T, Spiegel S. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol. 1998;142:229-240. (Pubitemid 28341153)
4. Allende ML, Proia RL. Sphingosine-1-phosphate receptors and the development of the vascular system. Biochim Biophys Acta. 2002;1582: 222-227.
5. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, Liu CH, Hla T, Spiegel S, Proia RL. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest. 2000;106:951-961.
6. Waeber C, Blondeau N, Salomone S. Vascular sphingosine-1-phosphate S1P(1) and S1P(3) receptors. Drug News Perspect. 2004;17:365-382.
7. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J. 2003;146:62-68.
8. Bolz SS, Vogel L, Sollinger D, Derwand R, Boer C, Pitson SM, Spiegel S, Pohl U. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation. 2003;108:342-347.
9. Watterson K, Sankala H, Milstien S, Spiegel S. Pleiotropic actions of sphingosine-1-phosphate. Prog Lipid Res. 2003;42:344-357.
10. Ikeda M, Kihara A, Igarashi Y. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyr-idoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun. 2004;325:338-343.
11. Jasinska R, Zhang QX, Pilquil C, Singh I, Xu J, Dewald J, Dillon DA, Berthiaume LG, Carman GM, Waggoner DW, Brindley DN. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters. Biochem J. 1999;340:677-686.
12. Le Stunff H, Galve-Roperh I, Peterson C, Milstien S, Spiegel S. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J Cell Biol. 2002;158:1039-1049.
13. Bolz SS, Pieperhoff S, de Wit C, Pohl U. Intact endothelial and smooth muscle function in small resistance arteries after 48 h in vessel culture. Am J Physiol Heart Circ Physiol. 2000;279:H1434-H1439.
14. Bolz SS, Pohl U. Highly effective non-viral gene transfer into vascular smooth muscle cells of cultured resistance arteries demonstrated by genetic inhibition of sphingosine-1-phosphate-induced vasoconstriction. J Vasc Res. 2003;40:399-405.
15. Bolz SS, de Wit C, Pohl U. Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2 + during acetylcholine-induced dilation of microvessels. Br J Pharmacol. 1999;128:124-134.
16. Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, Obeid LM. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra-and extracellular sphingosine-1-phosphate levels and cell viability. J Biol Chem. 2003;278:34541-34547.
17. Le Stunff H, Peterson C, Thornton R, Milstien S, Mandala SM, Spiegel S. Characterization of murine sphingosine-1-phosphate phosphohydrolase. J Biol Chem. 2002;277:8920-8927.
18. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation. 2003;107: 3081-3087.
19. Takuwa Y, Okamoto H, Takuwa N, Gonda K, Sugimoto N, Sakurada S. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol Cell Endocrinol. 2001;177:3-11.
20. Alemany R, Kleuser B, Ruwisch L, Danneberg K, Lass H, Hashemi R, Spiegel S, Jakobs KH, Meyer zu Heringdorf D. Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate. FEBS Lett. 2001;509:239-244.
21. Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, Hannun YA, Obeid LM. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem. 2001;276:35258-35264.
22. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110:1651-1658.
23. Bolz SS, Fisslthaler B, Pieperhoff S, de Wit C, Fleming I, Busse R, Pohl U. Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2 + ) changes and dilation in isolated resistance arteries. FASEB J. 2000;14:255-260.
24. Fameli N, van BC, Kuo KH. A quantitative model for linking Na( + )/ Ca(2 + ) exchanger to SERCA during refilling of the sarcoplasmic reticulum to sustain [Ca(2 + )] oscillations in vascular smooth muscle. Cell Calcium. 2007;42:565-575.
25. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA. 2006;103:16394-16399.
26. Valero M, Pereboom D, Garay RP, Alda JO. Role of chloride transport proteins in the vasorelaxant action of nitroprusside in isolated rat aorta. Eur J Pharmacol. 2006;553:205-208.